By Dennis ThompsonHealthDay Reporter WEDNESDAY, April 29, 2020 (HealthDay News) — COVID-19 might raise stroke risk in young and middle-aged adults, with virus-linked
Continue readingBENGALURU (Reuters) – Shares of Glenmark Pharmaceuticals Ltd (GLEN.NS) rose almost 9% on Thursday after the Indian drugmaker got an approval to conduct clinical trials with antiviral drug favipiravir,
Continue readingBy Amy NortonHealthDay Reporter TUESDAY, April 28, 2020 (HealthDay News) — With most Americans weeks into sheltering-in-place, couples are in a situation probably none
Continue reading“If we are to believe our colleagues in New York, 80% of the patients die on ventilator therapy. We have to change this therapy right now,” Groeneveld told Medscape. He’s been
Continue readingBy Dennis ThompsonHealthDay Reporter TUESDAY, April 28, 2020 (HealthDay News) — Supplies of personal protective equipment remain scarce across the United States, especially
Continue readingYet again, however, compliance depends on the culture at the institution. Trainees may be hesitant to report violations because they don’t want to get their employer in trouble. “You don’t
Continue readingWASHINGTON (Reuters) – U.S. drug regulators may announce their decision allowing emergency use of Gilead Science Inc’s experimental coronavirus drug remdesivir as soon as Wednesday, the New
Continue readingWhat your doctor is reading on Medscape.com: APRIL 28, 2020 — Differences are emerging between chest imaging findings in adults and children with COVID-19
Continue readingGENEVA (Reuters) – A top World Health Organization official declined comment on Wednesday on reports that Gilead Science’s remdesivir could help treat COVID-19, the respiratory disease caused
Continue readingBy Serena Gordon HealthDay Reporter WEDNESDAY, April 29, 2020 (HealthDay News) — Children don’t typically fall seriously ill from the new coronavirus, but doctors
Continue reading